Wafra Inc. Evolus, Inc. Transaction History

Wafra Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$3.03 - $5.48 $615,886 - $1.11 Million	-203,263 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.19 - $28.36 $1.38 Million - $2.97 Million	104,706 Added 106.24%	203,263 $2.97 Million
Q1 2019 May 13, 2019	BUY	$12.43 - $28.91 $603,563 - $1.4 Million	48,557 Added 97.11%	98,557 $2.22 Million
Q3 2018 Nov 13, 2018	BUY	$17.31 - $29.82 $865,499 - $1.49 Million	50,000 New	50,000 $931,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

Stay updated on Wafra Inc. with notifications on news.